Is port-site resection necessary in the surgical management of gallbladder cancer?

Fuks, David; Regimbeau, J.-M.; Pessaux, Patrick; Bachellier, Philippe; Raventos, Artivas; Mantion, Georges; Gigot, Jean‐François; Chiche, Laurence; Pascal, G.; Azoulay, Daniel; Laurent, Alexis; Létoublon, Christian; Boleslawski, Emmanuel; Rivoire, Michel; Mabrut, J.‐Y.; Adham, Mustapha; Treut, Yves-Patrice Le; Delpero, Jean‐Robert; Moreno-Navarro, Fernando; Ayav, Ahmet; Boudjéma, Karim; Nuzzo, Gennaro; Scotté, Michel; Farges, Olivier

doi:10.1016/j.jviscsurg.2013.03.006

Cited by 61 publications

(53 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, while patients with in-situ and intramucosal carcinomas are all alive after a mean follow-up of 69 months, T2 and T3 lesions showed, overall, an unsatisfactory prognosis with a median of 19 and 5 months for the two groups, respectively; these findings coincide with those reported by many authors [7,8,[12][13][14][15][16][17][18][19][20][21][22][23][24][25].…”

Section: Discussionsupporting

confidence: 89%

“…Furthermore, the frequent occurrence of the gallbladder carcinoma in the seventh and eighth life decade [3] (8 patients in our group are more than 75 years old) could make problematic the indication to a demanding surgical procedure comprising an extended liver resection and nodal dissection, in which are described postoperative complication rates up to 30-40% [8,9], even in the more recent literature [13][14][15][16][17][18][19][20][21][22][23][24][25].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Radical Surgery for Incidental Gallbladder Carcinoma. Which Subset of Patients is Really Suitable for?

Balcet¹,

Bossotti²,

Paolis³

2015

J Gastrointest Dig Syst

View full text Add to dashboard Cite

Background: There is a wide consensus on the fact that surgical treatment of incidental gallbladder carcinoma should be based according to T stage: while simple cholecystectomy is considered an adequate treatment for confined carcinomas to the lamina propria (T1a), it is still being discussed in the case of cancer limited to muscularis mucosae (T1b), and a secondary extended resection is the only curative option for tumors invading the perimuscolar connective tissue (T2), and seems to improve survival in selected advanced cases. However, it is still not clear which subset of patients is really suitable for aggressive reoperations, and their effective impact on the prognosis of incidental neoplasm. The purpose of this study is to evaluate these aspects in a retrospective review of gallbladder carcinomas diagnosed during or after 9284 cholecystectomies performed with a benign indication.

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Discussionmentioning

confidence: 99%

Radical Surgery for Incidental Gallbladder Carcinoma. Which Subset of Patients is Really Suitable for?

Balcet¹,

Bossotti²,

Paolis³

2015

J Gastrointest Dig Syst

View full text Add to dashboard Cite

show abstract

“…Various factors have been proposed that could possibly be involved in the development of such port site metastases [8]. In fact, port site resection has been attempted in patients with incidentally discovered GBC after laparoscopic cholecystectomy, although it has not been found to affect the outcome [9]. 18 F-FDG PET/CT is a robust tool in oncological imaging, useful in a variety of cancers.…”

Section: Discussionmentioning

confidence: 99%

Late Port Site Metastasis from Occult Gall Bladder Carcinoma After Laparoscopic Cholecystectomy for Cholelithiasis: The Role of 18F-FDG PET/CT

Sharma

Chatterjee

2014

Nucl Med Mol Imaging

View full text Add to dashboard Cite

Late port site metastasis of gall bladder carcinoma (GBC) after laparoscopic cholecystectomy is a rare finding. Rarer still is such a presentation where the GBC remained occult at histopathology. 18 F-flurodeoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/ CT) can play an important role in this setting by supporting the diagnosis of port site metastasis, by demonstrating additional sites of metastasis, if any, and by ruling out any other primary site. We here present two such patients with late port site metastasis of occult GBC after laparoscopic cholecystectomy for cholelithiasis and discuss the role of 18 F-FDG PET/CT in this setting.

show abstract

“…Port-site excision is to be considered in case when the diagnosis is made incidentally based on the histopathological assessment of the cholecystectomy specimen. The practice of excising port-sites is not routinely imposed as it does not modify the survival rate of these patients [10].…”

Section: Open and Laparoscopic Cholecystectomymentioning

confidence: 99%

Gallbladder Cancer: Surgical Management

Bartoș¹,

Herdean²,

Bartoş³

2017

Updates in Gallbladder Diseases

View full text Add to dashboard Cite

Gallbladder cancer represents one of the rare and highly fatal neoplastic diseases, early diagnosis and treatment being the key for an acceptable outcome. The best survival results are obtained for patients with T1-T2 stage, a radical cholecystectomy being sufficient in most of these cases. For advanced tumors, major liver resections could be necessary to obtain optimal oncological results. Although a high percentage of the patients are diagnosed with unresectable disease, the continuous progresses made in the field of surgical therapy and oncological treatment could finally improve the outcome of this neoplastic pathology.

show abstract

Is port-site resection necessary in the surgical management of gallbladder cancer?

Cited by 61 publications

References 23 publications

Radical Surgery for Incidental Gallbladder Carcinoma. Which Subset of Patients is Really Suitable for?

Radical Surgery for Incidental Gallbladder Carcinoma. Which Subset of Patients is Really Suitable for?

Late Port Site Metastasis from Occult Gall Bladder Carcinoma After Laparoscopic Cholecystectomy for Cholelithiasis: The Role of 18F-FDG PET/CT

Gallbladder Cancer: Surgical Management

Contact Info

Product

Resources

About